A patent infringement suit filed by Pfizer Inc. against Teva Parenteral Medicines Inc. relating to Zyvox (linezolid) is pending.
In December 2009, Teva Parenteral notified the Company that it had filed…
Patent infringement actions filed by Pfizer Inc. against Watson and Ranbaxy Laboratories Limited relating to Rapamune (sirolimus) are pending.
In March 2010, Watson and Ranbaxy notified the Company that they had…
Patent infringement actions filed by Pfizer Inc. against Lupin Limited and Novel Laboratories, Inc. relating to Lyrica (pregabalin) are pending.
In August and November 2010, respectively, Lupin and Novel notified the…
A patent infringement action filed by Novartis Vaccines and Diagnostics, Inc. against Wyeth relating to ReFacto and Xyntha is pending. The Company acquired Wyeth in 2009.
In February 2008, Novartis filed…
Patent infringement actions filed by Pfizer Inc. against against Teva USA with respect to Detrol LA (tolterodine) and against Ivax Pharmaceuticals, Inc., a wholly owned subsidiary of Teva USA, with…
Patent infringement actions filed by Pfizer Inc. against Teva Pharmaceutical Industries and Actavis, Inc. relating to Neurontin (gabapentin) were settled in May 2011.
Several years ago the Company filed patent-infringement actions…
A patent infringement suit filed by Pfizer Inc. against Impax Laboratories, Inc. relating to Detrol (tolterodine) is pending.
In April 2011, Impax notified the Company that it had filed an abbreviated…
A patent infringement action filed by Novartis Vaccines and Diagnostics, Inc. against a subsidiary of Wyeth relating to ReFacto and Xyntha is pending. The Company acquired Wyeth in 2009.
In May…
Patent infringement actions filed by Pfizer Inc. against Teva USA and Impax Laboratories, Inc. relating to Detrol LA (tolterodine) are ongoing.
In October 2007 and January 2008, respectively, Teva USA and…
A patent infringement suit filed by Pfizer Inc. against Mylan Pharmaceuticals Inc. relating to Sutent (sunitinib malate) is pending.
In May 2010, Mylan Pharmaceuticals Inc. notified the Company that it had…